Molecular Analysis of the PTEN, TP53 and CDKN2A Tumor Suppressor Genes in Long-term Survivors of Glioblastoma Multiforme
- 1 January 2000
- journal article
- research article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 48 (2) , 89-94
- https://doi.org/10.1023/a:1006402614838
Abstract
Despite multimodal therapy, glioblastoma multiforme (GBM) is associated with a poor prognosis with a median survival of less than 1 year. However, a small number of patients with GBM shows survival...Keywords
This publication has 40 references indexed in Scilit:
- Progression as exemplified by human astrocytic tumorsSeminars in Cancer Biology, 1999
- Primary and secondary glioblastomas: From concept to clinical diagnosisNeuro-Oncology, 1999
- TP53 alterations and clinical outcome in low grade astrocytomasGenes, Chromosomes and Cancer, 1994
- Long-Term Survival in Patients with Malignant AstrocytomaNeurosurgery, 1994
- Early Postoperative Magnetic Resonance Imaging after Resection of Malignant Glioma: Objective Evaluation of Residual Tumor and Its Influence on Regrowth and PrognosisNeurosurgery, 1994
- Long-term survival after the diagnosis of malignant glioma: A series of 22 patients surviving more than 4 years after diagnosisSurgical Neurology, 1992
- Effects of treatment on long‐term survivors with malignant astrocytomasAnnals of Neurology, 1990
- Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant gliomaJournal of Neurosurgery, 1989
- Ten-year survival among patients with supratentorial astrocytomas grade III and IVJournal of Neurosurgery, 1988
- Survival after Stereotactic Biopsy of Malignant GliomasNeurosurgery, 1988